Assignee
TEXAS BIOTECHNOLOGY CORP
US·34 granted patents·1 pending application·1,447 citations·filing 1994–2002
Top patents by PatentIndex Score
35 records- 0197US6545014B2Method of treating glaucomaTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Apr 8, 2003·50 cites·3 claims
- 0297US5571821ASulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Nov 5, 1996·125 cites·91 claims
- 0395US5594021AThienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1995·Granted Jan 14, 1997·88 cites·174 claims
- 0492US5962490AThienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Oct 5, 1999·93 cites·97 claims
- 0592US5510332AProcess to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides thereforTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Apr 23, 1996·151 cites·15 claims
- 0689US5444050ABinding of E-selectin or P-selectin to sialyl Lewisx or sialyl-LewisaTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Aug 22, 1995·93 cites·19 claims
- 0788US6458805B2Formulation of sulfonamides for treatment of endothelin-mediated disordersTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Oct 1, 2002·30 cites·65 claims
- 0888US5977117ASubstituted phenyl compounds and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Nov 2, 1999·72 cites·73 claims
- 0988US5591761AThiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Jan 7, 1997·67 cites·93 claims
- 1085US6723711B2Propanoic acid derivatives that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Apr 20, 2004·35 cites·13 claims
- 1183US6013655AThieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1998·Granted Jan 11, 2000·22 cites·27 claims
- 1282US5783705AProcess of preparing alkali metal salys of hydrophobic sulfonamidesTEXAS BIOTECHNOLOGY CORP·Filed 1997·Granted Jul 21, 1998·48 cites·11 claims
- 1381US6248767B1Formulation of sulfonamides for treatment of endothelin-mediated disordersTEXAS BIOTECHNOLOGY CORP·Filed 1997·Granted Jun 19, 2001·46 cites·66 claims
- 1481US6194448B1N, N-disubstituted amides that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Feb 27, 2001·42 cites·17 claims
- 1578US6632829B2Sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Oct 14, 2003·9 cites·55 claims
- 1678US6420567B1N-heteroaryl aryl-substituted thienyl-furyl-and pyrrolyl-sulfonamides and derviatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1997·Granted Jul 16, 2002·32 cites·73 claims
- 1778US5919768ADi- and trivalent small molecule selectin inhibitorsTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jul 6, 1999·61 cites·9 claims
- 1877US6432994B1Sulfonamides for treatment of endothelin-mediated disordersTEXAS BIOTECHNOLOGY CORP·Filed 1998·Granted Aug 13, 2002·30 cites·18 claims
- 1977US6030991ABenzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Feb 29, 2000·47 cites·125 claims
- 2077US5622937ACompositions and methods of inhibiting the binding of E-selectin or P-selectin or sialyl-Lewisx or sialyl-LewisaTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Apr 22, 1997·56 cites·6 claims
- 2176US6265428B1Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 24, 2001·34 cites·14 claims
- 2275US6331637B1N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Dec 18, 2001·26 cites·60 claims
- 2375US6087330AProcess to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides thereforTEXAS BIOTECHNOLOGY CORP·Filed 1998·Granted Jul 11, 2000·33 cites·17 claims
- 2473US6342610B2N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jan 29, 2002·18 cites·52 claims
- 2567US5804585AThieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Sep 8, 1998·22 cites·28 claims
- 2666US6262084B1Compounds that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 17, 2001·18 cites·10 claims
- 2763US5736509ACyclic peptide surface feature mimics of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Apr 7, 1998·19 cites·41 claims
- 2860US6376523B1Benzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Apr 23, 2002·19 cites·97 claims
- 2958US5776907AMitomycin oligonucleotide conjugatesTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jul 7, 1998·21 cites·16 claims
- 3055US5958905APhosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Sep 28, 1999·10 cites·92 claims
- 3154US5712387AHigh yield stereospecific mannosylationTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jan 27, 1998·8 cites·4 claims
- 3252US6329387B2Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Dec 11, 2001·10 cites·5 claims
- 3349US6713604B1Process to inhibit binding of the integrin α4β1 , to VCAM-1 fibronectin and cyclic peptides thereofTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Mar 30, 2004·7 cites·4 claims
- 3449US2003079238A1Polynucleotide encoding a human junctional adhesion protein (JAM-2)TEXAS BIOTECHNOLOGY CORP·Filed 2002·Application pending·0 cites
- 3546US6384261B1Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1998·Granted May 7, 2002·5 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when TEXAS BIOTECHNOLOGY CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →